|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/436 | |
| A61K 47/26 | |||
| A61K 9/14 | |||
| A61K 9/16 |
| (11) | Number of the document | 3054948 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14851643.8 |
| Date of filing the European patent application | 2014-10-07 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/059529 |
| Date | 2014-10-07 |
| (87) | Number | WO 2015/054280 |
| Date | 2015-04-16 |
| (30) | Number | Date | Country code |
| 201361888066 P | 2013-10-08 | US |
| (72) |
LICHENSTEIN, Henri, US
ROTHBERG, Jonathan M., US
ARMER, Thomas, US
MELVIN, Jr Lawrence S., US
|
| (73) |
AI Therapeutics, Inc.,
530 Old Whitfield Street, Guilford CT 06437,
US
|
| (54) | RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS |
| RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS |